Aa Aa Aa

Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines to meet the major unmet medical needs of patients on a global basis.

Find out more.


  • July 7, 2014

    Swissmedic Approves AMITIZA(R) (Lubiprostone) for the Treatment of Opioid-Induced Constipation

  • June 17, 2014

    AMITIZA(R) (Lubiprostone) Receives NICE Recommendation

  • June 12, 2014

    Sucampo Issues Statement Regarding Anesthetic and Analgesic Drug Products Advisory Committee Meeting’s Vote

  • May 29, 2014

    Sucampo Announces Webcast of Its Presentation at 2014 Jefferies Global Healthcare Conference